Ignite Creation Date:
2025-12-25 @ 4:05 AM
Ignite Modification Date:
2026-05-17 @ 4:37 PM
Study NCT ID:
NCT01521702
Status:
COMPLETED
Last Update Posted:
2015-03-20
First Post:
2011-12-22
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
NEOadjuvant Gemcitabine/Oxaliplatin Plus Adjuvant Gemcitabine in Resectable PAncreatic Cancer
Sponsor:
Institut Paoli-Calmettes
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
NEOPAC / IPC 2011-002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None